|
|
|
|
Marc Pierre Jean Dunoyer is Chief Financial Officer & Executive Director at AstraZeneca Plc and on the board of 5 other companies.
In the past he occupied the position of Global Head-Rare Diseases Unit at GlaxoSmithKline Plc and Chairman of GlaxoSmithKline KK (a subsidiary of GlaxoSmithKline Plc) and President-Asia Pacific at Hoechst Marion Roussel SA.
Mr. Dunoyer received an MBA from Hautes Etudes Commerciales and a graduate degree from University Paris-Sorbonne (Paris IV).
|
| Postes et responsabilités de Marc Dunoyer | |
|
| Nom | Titre |
Depuis |
 AstraZeneca PLC
(Produits pharmaceutiques) |
Chief Financial Officer & Executive Director |
2013 |  Orchard Therapeutics plc
(Produits pharmaceutiques) |
Independent Non-Executive Director |
2018 | | AstraZeneca KK |
Chairman |
- | | AstraZeneca UK Ltd. |
Director |
2013 | | Astrazeneca Intermediate Holdings Ltd. |
Director |
- | | Acerta Pharma BV |
Director |
- | | Orchard Therapeutics (Europe) Ltd. |
Independent Director |
2018 |
|
| Participations de Marc Dunoyer | |
|
| Nom | Actions | % | Valorisation |
AstraZeneca PLC (AZN)
(Produits pharmaceutiques) | 301 164 | 0,023% | 30 979 663 USD |
| Orchard Therapeutics PLC | 37 179 | 0,039% | 213 779 USD |
|
| Marc Dunoyer : Réseau personnel | |
|
|
© 2021 People and Ownership : 
|
|
|
| Marc Dunoyer : Connexions | |
|
|
| Dernières actualités sur Marc Dunoyer | |
|
|
|
|
Canada
Deutschland
España
Italia
Schweiz (DE)
United Kingdom
United States
bourse
